athenahealth (ATHN) Now Covered by Evercore ISI

Investment analysts at Evercore ISI initiated coverage on shares of athenahealth (NASDAQ:ATHN) in a report released on Thursday, MarketBeat reports. The brokerage set an “in-line” rating and a $140.00 price target on the health services provider’s stock. Evercore ISI’s price target would suggest a potential upside of 10.47% from the stock’s previous close.

Several other equities research analysts have also recently commented on ATHN. TheStreet cut athenahealth from a “b-” rating to a “c+” rating in a report on Wednesday, October 11th. Jefferies Group set a $110.00 price target on athenahealth and gave the company a “hold” rating in a report on Friday, October 13th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $167.00 price target on shares of athenahealth in a report on Tuesday, October 17th. Leerink Swann set a $155.00 price target on athenahealth and gave the company a “hold” rating in a report on Thursday, October 19th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $145.00 price target on shares of athenahealth in a report on Friday, October 20th. Two equities research analysts have rated the stock with a sell rating, seventeen have given a hold rating and eight have assigned a buy rating to the stock. athenahealth currently has an average rating of “Hold” and a consensus price target of $142.96.

Shares of athenahealth (ATHN) traded up $1.20 during trading on Thursday, hitting $126.73. The company’s stock had a trading volume of 55,782 shares, compared to its average volume of 420,500. athenahealth has a fifty-two week low of $95.01 and a fifty-two week high of $158.66. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $5,020.00, a PE ratio of 164.58, a P/E/G ratio of 2.95 and a beta of 1.58.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, beating the consensus estimate of $0.50 by $0.06. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The firm had revenue of $304.60 million during the quarter, compared to analysts’ expectations of $310.52 million. During the same quarter last year, the firm earned $0.60 earnings per share. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. equities analysts forecast that athenahealth will post 1.22 EPS for the current fiscal year.

In other athenahealth news, CEO Jonathan Bush sold 30,000 shares of the firm’s stock in a transaction on Tuesday, December 26th. The stock was sold at an average price of $134.80, for a total value of $4,044,000.00. Following the sale, the chief executive officer now directly owns 320,807 shares in the company, valued at $43,244,783.60. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amy Abernethy sold 500 shares of the firm’s stock in a transaction on Wednesday, December 26th. The shares were sold at an average price of $134.18, for a total value of $67,090.00. Following the completion of the sale, the director now owns 4,045 shares in the company, valued at $542,758.10. The disclosure for this sale can be found here. Over the last quarter, insiders sold 68,900 shares of company stock valued at $9,271,172. 3.20% of the stock is currently owned by company insiders.

A number of institutional investors have recently bought and sold shares of the business. FMR LLC raised its stake in athenahealth by 0.8% in the second quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock valued at $839,803,000 after buying an additional 47,341 shares in the last quarter. Janus Henderson Group PLC acquired a new stake in athenahealth in the second quarter valued at $713,856,000. Vanguard Group Inc. raised its stake in athenahealth by 1.8% in the second quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock valued at $435,795,000 after buying an additional 53,361 shares in the last quarter. Capital Research Global Investors raised its stake in athenahealth by 15.5% in the second quarter. Capital Research Global Investors now owns 2,041,714 shares of the health services provider’s stock valued at $286,963,000 after buying an additional 273,660 shares in the last quarter. Finally, BlackRock Inc. raised its stake in athenahealth by 2.0% in the second quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock valued at $229,377,000 after buying an additional 32,146 shares in the last quarter.

COPYRIGHT VIOLATION WARNING: “athenahealth (ATHN) Now Covered by Evercore ISI” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/18/athenahealth-athn-research-coverage-started-at-evercore-isi.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply